Explore / Clinical trial
Clinical trial

Shortened LSD Intervention for Major Depressive Disorder

Johns Hopkins UniversityNot yet recruitingPhase 1Started Oct 1, 202610 enrolledUnited StatesNCT07503002

Abstract

The purpose of this study is to determine the safety and clinical effectiveness of a shortened lysergic acid diethylamide (LSD) experience. This will be achieved by administering the drug risperidone 45-minutes after the administration of LSD.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

LSDDepression

Keywords

lysergic acid diethylamideMDDmajor depressionmajor depressiveMajor Depression ModerateMajor Depression SevereMajor Depression
View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

MFCC-DFT mapping of ligand recognition at the 5-HT<sub>2A</sub> receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.

Junior WSC, Bezerra KS, Matias EGC +2

Europe PMC2026
ArticlePsilocybin

Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.

Portes MAM, Bertoglio LJ

Europe PMC2026
ArticlePsilocybin

Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.

Vollebregt R, Storm AEM, Lucassen PJ +1

Europe PMC2026